Loading...
OTCM
IPAH
Market cap270kUSD
Nov 03, Last price  
0.00USD
Name

Interpharm Holdings Inc

Chart & Performance

D1W1MN
OTCM:IPAH chart
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
76m
+19.31%
29,700,00081,800,000100,800,000187,200,000107,400,00071,937,68053,051,12039,032,04341,100,00039,911,00063,355,00075,587,000
Net income
-14m
L+270.92%
-2,300,000800,0001,700,0002,700,000-4,300,000296,953-4,525,134-1,676,4083,123,000-149,000-3,790,000-14,058,000
CFO
-14m
L
-300,000-600,0003,000,000-1,300,000-600,000-1,589,6871,520,027-61,9882,126,000-2,353,000801,000-14,105,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Interpharm Holdings, Inc. specializes in the formulation, manufacturing, and commercialization of generic pharmaceuticals, encompassing both prescription-strength and over-the-counter varieties. The company's medicinal products are supplied to a wide array of clients, including significant retail chains, wholesale distributors, managed healthcare organizations, and nationwide distribution networks. Established in 1984, the firm maintains its principal operations in Hauppauge, New York.
URL
IPO date
Feb 12, 1993
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show